The Chest Pain And The Heart Attack.
For patients seen in exigency rooms solely for case pain, noninvasive screening tests may not always foreshadow time to come heart trouble, a new study suggests. Such tests include: electrocardiograms, which weigh the heart's electrical activity, echocardiograms, which quantity how well blood is flowing in the heart using ultrasound, and CT scans of the heart. All three tests are recommended for breast grieve under current guidelines, the study authors said found here. "It may be sound to defer early cardiac stress testing in patients with coffer pain but no evidence of a heart attack," said conduct researcher Dr Andrew Foy, an assistant professor of medication and public health sciences at the Penn State Milton S Hershey Medical Center in Hershey, PA.
Foy doesn't consider these tests are overused, but may not be needed in all cases. "Furthermore, primitive cardiac prominence testing appears to end in unnecessary, additional tests and invasive treatments". Around 6 million patients go to the pinch room with chest pain each year in the United States. "Therefore, these findings could striking the heedfulness of a large number of patients. Foy said that for patients with thorax pain not brought on by a heart attack, it seems safe to postpone early cardiac stress tests.
So "We would counsel they follow up closely with their primary care provider or cardiologist for the best advice on what to do after trunk pain. If the pain returns, then cardiac stress testing may certainly be reasonable, depending on the stamp of the pain and their other jeopardy factors for heart disease. The report was published online Jan 26, 2015 in the almanac JAMA Internal Medicine. For the study, Foy and his colleagues in use form insurance claims from a group of almost 700000 privately insured patients seen in difficulty rooms for chest pain in 2011.
From this group, they identified almost 422000 patients, of which more than 293000 did not be subjected to noninvasive tests and secluded to 128000 did. The most common test occupied was a myocardial perfusion scintigraphy - a scan that shows blood tide in the heart. According to Foy, the percentage of patients hospitalized for a compassion attack was only 0,11 percent a week after being seen in the crisis room and only 0,33 percent 190 days after being seen.
Patients who did not have monogram noninvasive tests were no more likely to have a heart attack than those who did come by testing, the researchers found. Patients who received these tests, however, were more seemly to have invasive procedures such as angioplasty. Yet these procedures did not promote the odds against having a heart attack. In an editor's note that accompanied the study, Dr Rita Redberg, editor-in-chief of JAMA Internal Medicine, said such tests in low-risk patients are needless and lengthen spell spent in the ER. "It is beat to change our guidelines and practice for treatment of chest pain in low-risk patients.
Such patients should be given a minute follow-up appointment with a primary sorrow physician who can determine, based on the patient's condition, whether further approximation is necessary". But Dr Gregg Fonarow, a professor of cardiology at the University of California, Los Angeles, said since the ponder researchers looked back at patients who went to the danger room and used material from insurance companies, the true value of these tests can't be definitively determined visit your url. Studies looking at patients in verifiable time constraint to be done to identify the value of these tests for low-risk chest sorrow patients.
No comments:
Post a Comment